ATA196973A - Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbon - Google Patents

Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbon

Info

Publication number
ATA196973A
ATA196973A AT731969A AT196973A ATA196973A AT A196973 A ATA196973 A AT A196973A AT 731969 A AT731969 A AT 731969A AT 196973 A AT196973 A AT 196973A AT A196973 A ATA196973 A AT A196973A
Authority
AT
Austria
Prior art keywords
dicarbone
dihydropyridine
amino
producing new
producing
Prior art date
Application number
AT731969A
Other languages
English (en)
Other versions
AT325614B (de
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2210650A external-priority patent/DE2210650C3/de
Priority claimed from DE19722260860 external-priority patent/DE2260860A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ATA196973A publication Critical patent/ATA196973A/de
Application granted granted Critical
Publication of AT325614B publication Critical patent/AT325614B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
AT196973A 1972-03-06 1973-03-06 Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbonsäureestern AT325614B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2210650A DE2210650C3 (de) 1972-03-06 1972-03-06 2-Amino-6-alkoxy-4,5-dihydropyridin-3,5-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE19722260860 DE2260860A1 (de) 1972-12-13 1972-12-13 Verfahren zur herstellung von neuen 2-amino-6-alkylmercapto-4,5-dihydropyridinen sowie ihre verwendung als antihypertensiva

Publications (2)

Publication Number Publication Date
ATA196973A true ATA196973A (de) 1975-01-15
AT325614B AT325614B (de) 1975-10-27

Family

ID=25762843

Family Applications (1)

Application Number Title Priority Date Filing Date
AT196973A AT325614B (de) 1972-03-06 1973-03-06 Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbonsäureestern

Country Status (16)

Country Link
US (1) US3876646A (de)
JP (1) JPS5626658B2 (de)
AT (1) AT325614B (de)
CA (1) CA985685A (de)
CH (1) CH580591A5 (de)
CS (1) CS179980B2 (de)
DD (1) DD106832A5 (de)
DK (1) DK135714C (de)
ES (1) ES412320A1 (de)
FR (1) FR2183673B1 (de)
GB (1) GB1374551A (de)
HU (1) HU167088B (de)
IE (1) IE37367B1 (de)
IL (1) IL41666A (de)
NL (1) NL7303134A (de)
SE (1) SE384206B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951993A (en) * 1972-03-06 1976-04-20 Bayer Aktiengesellschaft 2-Amino-4,5-dihydropyridine derivatives and process for their preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester
ZA7152B (en) * 1970-01-24 1971-10-27 Bayer Ag New pharmaceutically active 1,4-dihydropyridines
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
FR2183673B1 (de) 1976-12-03
DK135714B (da) 1977-06-13
GB1374551A (en) 1974-11-20
US3876646A (en) 1975-04-08
DK135714C (da) 1977-11-14
DD106832A5 (de) 1974-07-05
SE384206B (sv) 1976-04-26
CA985685A (en) 1976-03-16
IE37367B1 (en) 1977-07-06
FR2183673A1 (de) 1973-12-21
JPS4899180A (de) 1973-12-15
IL41666A (en) 1976-02-29
NL7303134A (de) 1973-09-10
JPS5626658B2 (de) 1981-06-19
HU167088B (de) 1975-08-28
AT325614B (de) 1975-10-27
CH580591A5 (de) 1976-10-15
ES412320A1 (es) 1976-04-16
CS179980B2 (en) 1977-12-30
IE37367L (en) 1973-09-06
IL41666A0 (en) 1973-05-31

Similar Documents

Publication Publication Date Title
AT329203B (de) Verfahren zur herstellung von neuen heptapeptiden
AT327181B (de) Verfahren zur herstellung von neuen phenylindanestern
ATA583473A (de) Verfahren zur herstellung von neuen sufonamidodiphenylathern
AT329045B (de) Verfahren zur herstellung von neuen, basisch substituierten indanderivaten
ATA779373A (de) Verfahren zur herstellung von neuen a-phenylindolderivaten
AT329198B (de) Verfahren zur herstellung von neuen n-(heteroaryl-methyl)-6,14-endoatheno-7alfa-hydroxyalkyl-tetrahydro-nororipavinen und -thebainen
AT328078B (de) Verfahren zur herstellung von neuen cyanomethylthioacetylcephalosporinen
AT327904B (de) Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen
AT342564B (de) Verfahren zur herstellung von neuen 11,12-secoprostaglandinen
AT327902B (de) Verfahren zur herstellung von neuen 3,4-dihydropyridonen
AT326841B (de) Verfahren zur herstellung von neuen 15alfa,16alfa-methylen-4-pregnenen
AT326842B (de) Verfahren zur herstellung von neuen 9,10-secoöstran-derivaten
ATA196973A (de) Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbon
AT326106B (de) Verfahren zur herstellung von neuen alkylphenolen
AT322104B (de) Verfahren zur herstellung von neuen pyrono-rifamycinen
AT327413B (de) Verfahren zur herstellung von neuen 15alpha,16alpha-methylen-4-ostren-17beta-olen
AT334879B (de) Verfahren zur herstellung von neuen arylathern
AT324298B (de) Verfahren zur herstellung von neuen substituierten bicycloalkenonen
AT323885B (de) Verfahren zur herstellung von neuen 3-formylrifamycinazinen
AT338229B (de) Verfahren zur herstellung von neuen aldehydolactonen
ATA1039174A (de) Verfahren zur herstellung von neuen 15alfa,16alfa-methylen-4-ostren-17beta-olen
ATA286873A (de) Verfahren zur herstellung von neuen 16-methylen-9beta,10alpha-steroiden
AT335627B (de) Verfahren zur herstellung von neuen 3',4'-anhydro-alfa,l-talomethylosiden
ATA76775A (de) Verfahren zur herstellung von neuen, basisch substituierten indanderivaten
AT324300B (de) Verfahren zur herstellung von neuen halogen substituierten phenylhydrazonen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee